Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease

por Gómez-Sámano, Miguel Ángel, Vargas-Abonce, Valerie Paola, Martínez-Sánchez, Froylan David, Palacios-Báez, Lucía, Vera-Zertuche, Juan Mauricio, Navarro-Flores, María Fernanda, Morales-García, Mariana Guadalupe, Fonseca-Correa, Jorge Ignacio, Zuarth-Vázquez, Julia María, Vega-Vega, Olynka, Correa-Rotter, Ricardo, Rincón-Pedrero, Rodolfo, Morales-Buenrostro, Luis E., Alberú-Gómez, Josefina, Ramírez-González, Julia Berenice, Pacheco-Domínguez, Reyna Lizette, López-Cervantes, Malaquías, Mendoza-de-la-Garza, María de los Ángeles, Baeza-Arias, Yolanda Victoria, Espinosa-Cuevas, Ángeles, López-Carrasco, Guadalupe, López-Estrada, Angelina, Guillén-Pineda, Luz Elizabeth, Gómez-Pérez, Francisco Javier, Cuevas-Ramos, Daniel
Publicado 2021